# Trade Mark Journal No.2026/022 29 May 2026

## UK00004387510 14 May 2026 (5,42)

SERENZA

Class 5
  Pharmaceutical and medical preparations for therapeutic purposes; biological preparations for medical use; pharmaceutical and biopharmaceutical preparations for medical use; medical preparations containing therapeutic DNA, RNA, polypeptides and antibodies; preparations for genetically modifying human or animal cells for medical purposes; biological, chemical and biochemical reagents for medical use; biologicals and small chemical entities, namely proteins, g-protein-coupled receptors, transmembrane proteins, g-proteins, antibodies and peptides for therapeutic purposes; cells for medical or clinical use; vaccines.
Class 42
  Scientific and industrial research and analysis in the field of life sciences; pharmaceutical and biopharmaceutical drug development services; biological research; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; pharmaceutical and biopharmaceutical research services, namely chemical and biological drug discovery services; medical research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; diagnostic services; medical research laboratory services; gene-editing services; providing a website featuring medical information and medical research; clinical trials; scientific and medical research and development in the field of biologicals and small molecules; biotechnology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services.

Serenza Therapeutics Ltd

Representative: Stratagem Intellectual Property Management Limited